Back to Results
First PageMeta Content
Mucokinetics / Pulmonology / Chronic obstructive pulmonary disease / Cystic fibrosis / Idiopathic pulmonary fibrosis / Cystic Fibrosis Foundation / Health / Medicine / National Institutes of Health


2800 Meridian Parkway, Suite 195 Durham, North Carolina[removed]1180 (phone) Contact: Paul Boucher President, Parion Sciences
Add to Reading List

Document Date: 2014-10-15 09:25:42


Open Document

File Size: 392,25 KB

Share Result on Facebook

City

Durham / /

Company

Academic Partners / Cystic Fibrosis Foundation Therapeutics Inc. / Parion Sciences / Advanced Diagnostics / /

Currency

USD / /

/

Event

FDA Phase / Funding / /

Facility

The University of Colorado / Chapel Hill / And Blood Institute / The University of North Carolina / /

IndustryTerm

stage biopharmaceutical / treatment of these diseases / chemical compounds / /

MedicalCondition

COPD / pulmonary and ocular diseases / Lung Disease / diseases / acute and chronic pulmonary disorders / Cystic Fibrosis / /

NaturalFeature

Chapel Hill / /

Organization

National Institute of Health / University of Colorado / Denver / FDA / University of North Carolina / Chapel Hill / And Blood Institute of the National Institutes of Health / /

Person

Paul Boucher / /

/

Position

President / /

Product

Investigational New Drug / /

ProvinceOrState

North Carolina / Colorado / /

URL

www.Parion.com / /

SocialTag